Cargando…
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
Background. Cutaneous malignant melanoma (CMM) is a heterogeneous disease, acknowledged for its lack of predictability regarding clinical evolution. In order to appreciate a patient's individual prognosis, an attempt is made to find new tumor markers that parallel the disease progression. Objec...
Autores principales: | Sandru, Angela, Panaitescu, Eugenia, Voinea, Silviu, Bolovan, Madalina, Stanciu, Adina, Cinca, Sabin, Blidaru, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090457/ https://www.ncbi.nlm.nih.gov/pubmed/25045539 http://dx.doi.org/10.1155/2014/843214 |
Ejemplares similares
-
Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Simultaneous determination of two serum tumor markers in assessing malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Survival rates of patients with metastatic malignant melanoma
por: Sandru, A, et al.
Publicado: (2014) -
Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma
por: Voinea, S, et al.
Publicado: (2016)